Increasing the proteolytic activity of proteasome enhances the degradation of specific intrinsically disordered proteins (IDPs) such as α-synuclein, β-amyloid, and tau, to mention a few, which are associated with the pathogenesis of these neurodegenerative diseases. This evidence concerns the gene MAPT and neurodegenerative disease.